Evidence map›Paper›PMID 40269446›Full record

ArticleJournal of public health (Oxford, England)2025

Does the name of a disease matter? Chinese people's public perception of the renaming of COVID-19.

Mengru Han, Yan Gu

Abstract read
In one paragraph

Article in Journal of public health (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mengru HanDepartment of Chinese Language and Literature, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China.
Yan GuDepartment of Psychology, University of Essex, Wivenhoe Park, Valley Road, Colchester CO4 3SQ, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOn 7 December 2022, China discontinued its 3-year zero-COVID strategy, and on 26 December 2022, changed the name of COVID-19 from [novel coronavirus pneumonia (NCP)] to [novel coronavirus infection (NCI)]. This study examined whether the renaming influenced public perception of COVID-19's severity right after the change, despite the Omicron variant itself remaining unchanged.

methodsA survey was conducted immediately following the renaming in China. Participants were asked to directly compare the two names, and indirectly questioned about their perceptions of the virus. Responses were compared to assess whether linguistic framing with NCP or NCI influenced perceptions.

resultsDirect comparisons showed that 65% of respondents (N = 1256) perceived the new name as less serious and frightening than the old one. However, one-third of participants did not perceive such differences, which was associated with their education level, age, and relationship status. Indirect comparisons revealed that perceived severity of COVID-19 was influenced by an interaction between wording in names and participants' intensity of COVID-19 experience.

conclusionsLinguistic framing, personal experience, and sociodemographic factors can all influence disease perceptions during health crises. Optimizing naming strategies can reduce public anxiety and enhance health communication.

Indexed as

COVID-19Public OpinionTerminology as TopicAdultAgedChinaEast Asian PeopleFemaleHumansMaleMiddle AgedSARS-CoV-2Surveys and QuestionnairesYoung AdultCOVID-19health communicationlanguage and thoughtlinguistic framingnaming a diseasepublic perception

Identifiers

PMID40269446
PMCPMC12395955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.